Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.5B | 20.9B | 15.6B | 13.2B |
Cost of revenue | 7.4B | 18.9B | 13.4B | 11.4B |
Gross profit | 2.1B | 1.9B | 2.2B | 1.9B |
Operating expense | ||||
Research & development | 338.8M | 978.3M | 610.7M | 519.6M |
Selling general and admin | 820.4M | -1.3B | 2.1B | -393.5M |
Other operating expenses | 47.2M | 130.6M | 64.0M | 50.4M |
Operating income | 918.4M | 194.4M | 529.1M | 806.5M |
Non operating interest income | ||||
Income | 110.9M | 127.1M | 92.2M | 124.9M |
Expense | 250.2M | 303.7M | 295.1M | 316.7M |
Other income expense | — | — | — | — |
Pretax income | 850.3M | -260.1M | 519.0M | 1.3B |
Tax provision | 182.3M | -253.9M | 92.3M | 273.4M |
Net income | 668.0M | -6.2M | 426.7M | 1.0B |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 35.9B | — | — | — |
Diluted average shares | 36.1B | — | — | — |
EBITDA | 1.0B | 807.0M | 799.9M | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | -99.8M | 74.6M | -21.4M | 4.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |